Acasti Pharma Intangible Assets

Acasti Pharma (ACST) currently reports a intangible assets of $28M as of June 2026. That compares with $41M in the prior-year period — down 32.9% year over year. Use the charts on this page to explore Acasti Pharma's intangible assets history and peer comparisons.

Acasti Pharma's intangible assets decreased from $41M to $28M — a 32.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acasti Pharma reported $28M in intangible assets as of June 2026. That compares with $41M in the prior-year period — down 32.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $28M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acasti Pharma, and consider following ACST for alerts when major investors trade the stock.

Acasti Pharma is classified in the Healthcare sector. On intangible assets, it currently shows $28M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACST with unrelated industries.